MoFo Life Sciences

November 20, 2020 - United States, FDA, COVID-19
FDA Authorizes First Full At-Home Test for the Detection of SARS-CoV-2
On November 17, 2020, FDA issued the long-awaited first emergency use authorization (EUA) for a COVID-19 diagnostic test for self-testing at home. The test, the Lucira COVID-19 All‑In‑One Test Kit, can be conducted completely at home by anyone age 14 or over, by collecting
... ›
November 17, 2020 - United States, FDA, Healthcare
Recent Digital Health-Related FDA Announcements
By: Jean Nguyen Ph.D.
The U.S. Food and Drug Administration (FDA) is showing its dedication to the advancement of digital health technology with two recent announcements: a new Digital Health Center of Excellence and an update on its Software Precertification Program. Manufacturers developing mobile medical devices, software as
... ›
November 17, 2020 - United States, Corporate + Venture Capital, United Kingdom, Startup, Intellectual Property
GSAS Harvard Biotech Club and Morrison & Foerster’s New Course
By: Andrew Boyd, Alfredo B. D. Silva, Anita Choi and Michael Ward Ph.D.
MoFo & GSAS Harvard Biotech Club’s new course, “ Legal Topics for Scientists, Entrepreneurs, and Start Ups ,” started on November 11, with more than 100 life sciences graduate students, post-docs, and industry professionals. The Harvard Biotech Club is a student organization that seeks to
... ›
November 09, 2020 - Licensing + Commercial, United States, Corporate + Venture Capital, FDA, United Kingdom, Litigation, Startup, Regulatory, Intellectual Property, Announcements
Legal Topics for Scientists, Entrepreneurs, and Start Ups
By: Michael Ward Ph.D., Anita Choi, Andrew Boyd, Alfredo B. D. Silva, Matthew Karlyn, Jim Krenn and Matthew A. Chivvis
The GSAS Harvard Biotech Club and Morrison & Foerster course on Legal Topics for Scientists, Entrepreneurs, and Start Ups features a combination of lectures and interactive workshops and is designed for students, post-docs, entrepreneurs, and investors with life sciences and tech backgrounds to learn
... ›
October 17, 2020 - Licensing + Commercial, United States, Corporate + Venture Capital
Life Sciences Startup: Top Things to Keep in Mind About Formation and License Agreements
By: Steve Rowles, Matthew Karlyn and Michael Ward Ph.D.
During our fifth Patent Law Course session offered by Morrison & Foerster and GSAS Harvard Biotech Club , Steve Rowles , firmwide co-chair of the Emerging Companies & Venture Capital Group , chair of MoFo’s San Diego Corporate Group, and managing partner of the
... ›
October 15, 2020 - United States, FDA, Regulatory
Bill Proposes Continuation of FDA Rare Pediatric Disease Priority Review Vouchers
Morrison & Foerster Research Analyst Christine Lentz contributed to the writing of this article. The House of Representatives recently passed a proposed bill that encourages treatments for rare pediatric diseases by prolonging the authority of Health and Human Services to issue priority review vouchers.
... ›
October 07, 2020 - United States, FDA, Litigation, Intellectual Property
Navigating The CRISPR Patent Landscape and Understanding The FDA and its Process
By: Michael Ward Ph.D.
“What can be a better day to talk about the complex CRISPR/Cas9 patent landscape than the big day that the Nobel Prize was awarded to pioneers of this revolutionary technology? The story of the continuing dispute on the fundamental CRISPR/Cas9 patents offers a lot
... ›
October 01, 2020 - AI + Robotics, United States, Intellectual Property
Special Patents and AI with Janet Xiao and Anna Yuan
By: Janet Xiao Ph.D., Anna Yuan and Michael Ward Ph.D.
In this third installment of a six-part Patent Law Course offered by Morrison & Foerster and GSAS Harvard Biotech Club , MoFo partner and head of the firm’s China Life Sciences Group Janet Xiao taught a class on the value, protection, and legal issues involved
... ›
September 28, 2020 - United States, Intellectual Property
Patent Drafting with James Mullen - GSAS Harvard Biotech Club & MoFo's Patent Course
By: Michael Ward Ph.D.
Morrison & Foerster LLP partner, founder and head of MoFo’s antibody IP practice James Mullen taught a class in patent drafting to members of the GSAS Harvard Biotech Club (HBC). This was the second of a six-part Patent Law Course offered by Morrison &
... ›
September 22, 2020 - Licensing + Commercial, United States, FDA, Startup, Data Analytics, Intellectual Property
GSAS Harvard Biotech Club and Morrison & Foerster’s Patent Course Off to a Roaring Start!
By: Michael Ward Ph.D., Matthew Karlyn, Janet Xiao Ph.D., Matthew A. Chivvis, Jie Zhou Ph.D., Anna Yuan and Jillian A. Pesin-Fulop Ph.D.
More than 120 life sciences graduate students, post-docs and industry professionals attended the first class of a six part Patent Law Course offered by Morrison & Foerster and the GSAS Harvard Biotech Club on September 16, 2020. The Harvard Biotech Club is a student
... ›

Topic Archives: United States

FDA Authorizes First Full At-Home Test for the Detection of SARS-CoV-2

Recent Digital Health-Related FDA Announcements

By: Jean Nguyen Ph.D.

GSAS Harvard Biotech Club and Morrison & Foerster’s New Course

By: Andrew Boyd, Alfredo B. D. Silva, Anita Choi and Michael Ward Ph.D.

Legal Topics for Scientists, Entrepreneurs, and Start Ups

By: Michael Ward Ph.D., Anita Choi, Andrew Boyd, Alfredo B. D. Silva, Matthew Karlyn, Jim Krenn and Matthew A. Chivvis

Life Sciences Startup: Top Things to Keep in Mind About Formation and License Agreements

By: Steve Rowles, Matthew Karlyn and Michael Ward Ph.D.

Bill Proposes Continuation of FDA Rare Pediatric Disease Priority Review Vouchers

Navigating The CRISPR Patent Landscape and Understanding The FDA and its Process

By: Michael Ward Ph.D.

Special Patents and AI with Janet Xiao and Anna Yuan

By: Janet Xiao Ph.D., Anna Yuan and Michael Ward Ph.D.

Patent Drafting with James Mullen - GSAS Harvard Biotech Club & MoFo's Patent Course

By: Michael Ward Ph.D.

GSAS Harvard Biotech Club and Morrison & Foerster’s Patent Course Off to a Roaring Start!

By: Michael Ward Ph.D., Matthew Karlyn, Janet Xiao Ph.D., Matthew A. Chivvis, Jie Zhou Ph.D., Anna Yuan and Jillian A. Pesin-Fulop Ph.D.